[Focus] A new strategy to ERADicate HER2-positive breast tumors?

Targeting a proteotoxic stress response pathway may improve therapeutic outcomes for HER2-positive breast cancer patients.

Source: Signal Transduction Knowledge Environment - May 22, 2015 Category: Science Authors: Sanjeevani Arora and Erica A. Golemis Source Type: news